Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced h…
| Periodo | 2026-08 |
|---|---|
| Real | — |
| Estimado | — |
| Sorpresa | — |
| Métrica | PMI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -4.1% | 57.4% | -61.5% |
| Operating Margin | -268.4% | -34.4% | -234.0% |
| Net Margin | -546.6% | -32.5% | -514.1% |
| FCF Margin | — | -12.6% | — |
| ROE | -712.6% | -39.2% | -673.5% |
| ROA | -119.8% | -30.9% | -88.8% |
| Current Ratio | 1.11 | 2.73 | -1.62 |
| Debt / Equity | 0.00 | 0.28 | -0.28 |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -119.8% | — |
| ✗Flujo de caja operativo positivo | −$16M | −$12M |
| ✓Rentabilidad sobre activos al alza | -119.8% | -173.9% |
| ✓Caja operativa/activos supera al ROA | -69.5% | ROA -119.8% |
| ✗Menos deuda a largo plazo | 0.0% | 0.0% |
| ✓Mejor liquidez (ratio corriente) | 1.11 | 0.28 |
| ✗Sin aumentar el nº de acciones | — | — |
| ✗Margen bruto al alza | -4.1% | -2.6% |
| ✗Rotación de activos al alza | 0.22 | 0.36 |
| Calidad del negocio | FY25 |
|---|---|
| ✗ROCE > 10 % | -344.1% |
| ✓Deuda neta/EBITDA < 3x | Caja neta |
| ✓Reinversión (I+D + capex) > 3 % de ventas | 61.7% |
Picard Medical, Inc. cotiza a 12.75 USD y tiene una capitalización bursátil de $30M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud